View Author
Nobels, F.R.E.
(Frank Nobels)
patient tumours neuroendocrine level serum tumour tumor adenomas marker neuroendocrine tumours concentration treatment hormone dopamine a-subunit chromogranin study secretion subject quinagolide receptor gonadotropin volume endocrinol effect carcinoma carcinoid tissue value peptide agonist metab chapter serum levels serum concentrations syndrome month pituitaly control response subunit nonfunctioning lambert presence therapy neuroendocrine tumors gonadotroph adenoma neuroendocrine cells result neoplasm diagnosis cga levels dopamine agonists serum marker bromocriptine basal cell lung carcinoma cushing growth tumour volume nobel pheochromocytoma production release kwekkeboom 0.5 ectopic carcinoid tumours origin increase pancreatic table field defects uptake cancer somatostatin group secreting lamberts swj
3 Most Recent Publications
|
Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma
(Article)
Nobels, F.R.E. Herder, W.W. de Brink, W.M. van den Kwekkeboom, D.J. Hofland, L.J. Zuyderwijk, J. Jong, F.H. de Lamberts, S.W.J. |
2000-01-01
|
|
Neuroendocrine Tumour Markers
(Doctoral Thesis)
Nobels, F.R.E. |
1999-09-22
|
|
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones
(Article)
Nobels, F.R.E. Kwekkeboom, D.J. Coopmans, W. Schoenmakers, C.H.H. Lindemans, J. Krenning, E.P. Bouillon, R. Lamberts, S.W.J. Herder, W.W. de |
1997-01-01
|
